HighLife Medical said today that it raised more than $14 million for the replacement heart valve it’s developing to treat mitral regurgitation. Paris- and Irvine, Calif.-based HighLife said the €12.3 million round was led by European venture capital shop Soffinova Partners, joined by prior backers LivaNova (NSDQ:LIVN) and HighLife founder & CEO Georg Börtlein – who also co-founded […]
Funding Roundup
CorInnova raises $6m for EpicHeart soft robotic heart failure treatment
CorInnova said today that it raised $6.1 million from Wellcome Trust for the EpicHeart device it’s developing to treat heart failure. Houston-based CorInnova said EpicHeart is a direct cardiac compression device that uses a collapsible, thin-film, pneumatically actuated soft robotic device to surround both ventricles of the heart. It’s designed to use air to inflate and […]
Pacira to invest up to $25m in surgical reconstruction company
Pacira Pharmaceuticals (NSDQ:PCRX) plans to invest up to $25 million in privately-held surgical reconstruction company Tela Bio, the company said today. Pennsylvania-based Tela Bio has a portfolio of reinforced bioscaffold products, called OviTex, which combine biologic and synthetic materials in an embroidered implant that allows fluid and cells to move freely through the device. The implants […]
Siemens taps banks for upcoming Healthineers IPO
Siemens (NYSE:SI) reportedly tapped a trio of banks for the upcoming initial public offering for its Healthineers business. The IPO, which could wind up being one of the largest German flotations in years, is slated to go live during the first half of 2018, Reuters reported. The industrial conglomerate named Goldman Sachs, Deutsche Bank and JP Morgan […]
Lumicell raises $21m for image-guided cancer surgery tech
Lumicell has raised $20.7 million over the past three months, according to a regulatory document filed with SEC last week. More than 20 investors have contributed to the $26.5 million equity offering, the Wellesley, Mass.-based company reported, including one investor outside of the U.S. Get the full story at our sister site, Drug Delivery Business News.
NeuroPace raises $74m for anti-epilepsy implant
NeuroPace said today that it raised a $74 million funding round, saying it plans to use the infusion to speed the commercialization of its implantable neurostimulation device for treating epilepsy. Mountain View, Calif.-based NeuroPace said the round was led by the KCK Group and OrbiMed Advisors. NeuroPace’s RNS system monitors electrical activity in the brain, delivering stimulative therapy […]
OptiNose IPO pulls in $120m
OptiNose (NSDQ:OPTN) raised $120 million with its initial public offering last week, adding $20 million to the target is set earlier this month. Yardley, Penn.-based OptiNose floated 7.5 million shares at $16 apiece in the offering, above the range it set Oct. 3 for 6.3 million shares at $15 to $17 apiece. Get the full story at our sister […]
Tandem prices $16m public offering
Tandem Diabetes Care (NSDQ:TNDM) today priced an underwritten public offering of 4,630,000 shares of its common stock, Series A warrants and Series B warrants to buy 4,630,000 shares of common stock at $3.50 apiece. The San Diego, Calif.-based company said it expects to bring in $16.2 million in gross proceeds from the offering. Get the full story at […]
UC-Berkeley gets in on medtech accelerator in India
The University of California-Berkeley is reportedly getting in on a medtech accelerator in India, aiming to take local startups from the seed-funding stage to Series A rounds. The Bengaluru-based program, launched with incubator IKP Eden, plans to enroll 15 startups for each 18-week course, according to the Economic Times. The accelerator has so far accepted […]
Robotic hair transplant dev Restoration Robotics raises $25m in IPO
Robotic hair restoration company Restoration Robotics has raised $25 million in an initial public offering and seen its shares rise nearly 40% after its debut, according to a Silicone Valley Business Journal report. The 91-person company, co-founded by surgical robotics pioneer Fred Moll, sold 3.6 million shares at $7 each, then proceeded to open at […]
OrthoPediatrics prices $52m IPO
OrthoPediatrics today priced its initial public offering at $13 per share, meaning the 4-million-share flotation pulled in $52 million for its line of surgical systems for children. The offering includes a 30-day underwriters over-allotment of 600,000 extra shares, which if fully exercised would push the IPO’s total raise to $59.8 million. Warsaw, Ind.-based OrthoPediatrics produces 21 surgical […]